Home  »  Stock   »  Arcutis Biotherapeutics Inc. (ARQT): Does this sto...

Arcutis Biotherapeutics Inc. (ARQT): Does this stock hold the most enticing factor today?

Let’s start up with the current stock price of Arcutis Biotherapeutics Inc. (ARQT), which is $17.73 to be very precise. The Stock rose vividly during the last session to $18.75 after opening rate of $18.40 while the lowest price it went was recorded $17.58 before closing at $18.31.Recently in News on November 21, 2022, Arcutis Biotherapeutics Publishes First Environmental, Social, and Governance (ESG) Report. Report highlights efforts to advance diversity and inclusion, access to medicine, sustainable business practices, and governance. You can read further details here

Arcutis Biotherapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $27.40 on 08/31/22, with the lowest value was $13.59 for the same time period, recorded on 01/28/22.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


Arcutis Biotherapeutics Inc. (ARQT) full year performance was 1.26%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcutis Biotherapeutics Inc. shares are logging -35.29% during the 52-week period from high price, and 30.46% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $13.59 and $27.40.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 545393 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Arcutis Biotherapeutics Inc. (ARQT) recorded performance in the market was -14.51%, having the revenues showcasing -24.95% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.08B, as it employees total of 147 workers.

The Analysts eye on Arcutis Biotherapeutics Inc. (ARQT)

During the last month, 7 analysts gave the Arcutis Biotherapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 21.06, with a change in the price was noted -4.24. In a similar fashion, Arcutis Biotherapeutics Inc. posted a movement of -19.28% for the period of last 100 days, recording 706,685 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARQT is recording 0.73 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.73.

Technical rundown of Arcutis Biotherapeutics Inc. (ARQT)

Raw Stochastic average of Arcutis Biotherapeutics Inc. in the period of last 50 days is set at 34.61%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 39.29%. In the last 20 days, the company’s Stochastic %K was 48.21% and its Stochastic %D was recorded 55.13%.

Considering, the past performance of Arcutis Biotherapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -14.51%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -9.54%, alongside a boost of 1.26% for the period of the last 12 months. The shares increased approximately by -7.80% in the 7-day charts and went down by 4.17% in the period of the last 30 days. Common stock shares were lifted by -24.95% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts